p12 isoform‐2 is a regulatory subunit of human <scp>DNA</scp> polymerase delta and is dysregulated in various cancers

Dysregulation of human DNA polymerase delta (Polδ) subunits is associated with genome instability and pathological disorders. Genome databases suggest the expression of several spliced variants of subunits which may alter Polδ function. Here, we analyzed the protein-encoding variants of the Polδ subunit p12 and their association with cancer. p12 isoform-2 (p12*) encodes a 79 aa protein with a C-terminal tail distinct from the previously characterized p12. Like p12, p12* dimerizes and interacts with p125 and p50 subunits and is thus an integral component of Polδ. Further, we observed dysregulated p12* expression in low-grade glioma, renal, thyroid, and pancreatic carcinomas. This study identifies a previously unrecognized Polδ complex and highlights a possible regulatory role of p12 variants in cellular phenotypes.

Authors

Institutions

Publication Details

Journal
FEBS Letters
Published
2024-12-01
DOI
https://doi.org/10.1002/1873-3468.15070
Citations
3
Primary Topic
Cancer-related Molecular Pathways
Type
article
Field-Weighted Citation Impact
0.85

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

p12 isoform‐2 is a regulatory subunit of human DNA polymerase delta and is dysregulated in various cancers

Jugal Kishor Sahu, Narottam Acharya, Ipsita Subhadarsini, Shweta Thakur
3 citations
FEBS Letters
Cancer-related Molecular Pathways
0.85
article

p12 isoform‐2 is a regulatory subunit of human DNA polymerase delta and is dysregulated in various cancers

Jugal Kishor Sahu, Narottam Acharya, Ipsita Subhadarsini, Shweta Thakur
article en
3 citations

Abstract

Dysregulation of human DNA polymerase delta (Polδ) subunits is associated with genome instability and pathological disorders. Genome databases suggest the expression of several spliced variants of subunits which may alter Polδ function. Here, we analyzed the protein-encoding variants of the Polδ subunit p12 and their association with cancer. p12 isoform-2 (p12*) encodes a 79 aa protein with a C-terminal tail distinct from the previously characterized p12. Like p12, p12* dimerizes and interacts with p125 and p50 subunits and is thus an integral component of Polδ. Further, we observed dysregulated p12* expression in low-grade glioma, renal, thyroid, and pancreatic carcinomas. This study identifies a previously unrecognized Polδ complex and highlights a possible regulatory role of p12 variants in cellular phenotypes.

FEBS LettersVol. 598(24)
Regional Centre for Biotechnology (IN), Institute of Life Sciences (IN)
Department of Biotechnology, Ministry of Science and Technology, India
Good health and well-being
Openalex Percentile: Top 21%
Cancer-related Molecular Pathways
0.85
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.